000 | 01342 a2200409 4500 | ||
---|---|---|---|
005 | 20250512113014.0 | ||
264 | 0 | _c19740115 | |
008 | 197401s 0 0 eng d | ||
022 | _a0007-1447 | ||
024 | 7 |
_a10.1136/bmj.4.5885.147 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAkinyanju, O | |
245 | 0 | 0 |
_aPyrimethamine poisoning. _h[electronic resource] |
260 |
_bBritish medical journal _cOct 1973 |
||
300 |
_a147-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAnemia, Macrocytic _xchemically induced |
650 | 0 | 4 |
_aAtaxia _xchemically induced |
650 | 0 | 4 |
_aBlindness _xchemically induced |
650 | 0 | 4 |
_aCentral Nervous System _xdrug effects |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aDeafness _xchemically induced |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFever _xchemically induced |
650 | 0 | 4 |
_aFolic Acid _xtherapeutic use |
650 | 0 | 4 | _aFolic Acid Antagonists |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aIntellectual Disability _xchemical synthesis |
650 | 0 | 4 |
_aLeucovorin _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPyrimethamine _xmetabolism |
700 | 1 | _aGoddell, J C | |
700 | 1 | _aAhmed, I | |
773 | 0 |
_tBritish medical journal _gvol. 4 _gno. 5885 _gp. 147-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.4.5885.147 _zAvailable from publisher's website |
999 |
_c4547280 _d4547280 |